HCA Healthcare Inc (HCA) has demonstrated impressive financial resilience, boasting an EPS growth of 29.09% year-over-year and consistently beating earnings estimates, with Q4 2025 actual EPS at $8.14 against an estimate of $7.53. The current price of $505.12 reflects a market cap of approximately $113B, and despite a recent 48% surge over the last year, the P/E ratio of 16.67 suggests that the stock is reasonably valued relative to its growth potential. The 52-week high stands at $556.52, indicating further upside potential.